Dhania Novitasari

6PUBLICATIONS
19CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Current Study of Alpha-Mangostin in Breast Cancer Therapy: Antioxidant Mechanisms and Redox Modulation from In Silico to In Vivo Studies.

|Sep 15, 2025
Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources.

Taufik Muhammad Fakih, Dhania Novitasari, Mukh Syaifudin

|Dec 04, 2024
The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies.

Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato

|Aug 08, 2022
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties.

Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari

|Jun 28, 2021
CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells.

Dhania Novitasari, Riris Istighfari Jenie, Rohmad Yudi Utomo

|Jan 28, 2021
The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells.

Riris Istighfari Jenie, Rohmad Yudi Utomo, Ratna Asmah Susidarti

Pageof 1

Frequent Collaborators

5 joint publications

Edy Meiyanto

3 joint publications

Riris Istighfari Jenie

3 joint publications

Rohmad Yudi Utomo

2 joint publications

Muchtaridi Muchtaridi